Home LiteratureArticle Details
PMID: 22150037 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Inflammatory cortical demyelination in early multiple sclerosis.

The New England journal of medicine ·Vol. 365 ·No. 23 ·2011-12-08 ·Pages 2188-97

Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM

Abstract

Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with long-standing, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56%) at the last follow-up visit (at a median of 3.5 years). Cortical demyelination was present in 53 patients (38%) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81% of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72% of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82%) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41%) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.).

MeSH Terms
Biopsy Cerebral Cortex/immunology,pathology Humans Inflammation/pathology Logistic Models Multiple Sclerosis/immunology,pathology Neurodegenerative Diseases/pathology Prevalence
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Lucchinetti Claudia F
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. lucchinetti.claudia@mayo.edu
Popescu Bogdan F G
Bunyan Reem F
Moll Natalia M
Roemer Shanu F
Lassmann Hans
Brück Wolfgang
Parisi Joseph E
Scheithauer Bernd W
Giannini Caterina
Weigand Stephen D
Mandrekar Jay
Ransohoff Richard M
References (49)
49 references, click to expand
  1. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.
    J Magn Reson Imaging. 2006 May;23(5):628-36 PMID: 16565955
  2. Cortical lesions in multiple sclerosis.
    Nat Rev Neurol. 2010 Aug;6(8):438-44 PMID: 20625376
  3. Subpial demyelination in the cerebral cortex of multiple sclerosis patients.
    J Neuropathol Exp Neurol. 2003 Jul;62(7):723-32 PMID: 12901699
  4. Cortical lesions in multiple sclerosis.
    Brain. 1999 Jan;122 ( Pt 1):17-26 PMID: 10050891
  5. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.
    Brain Pathol. 2004 Apr;14(2):164-74 PMID: 15193029
  6. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
    Ann Neurol. 2001 Jul;50(1):121-7 PMID: 11456302
  7. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.
    Brain. 2006 Aug;129(Pt 8):1972-83 PMID: 16714315
  8. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.
    Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8389-94 PMID: 12829791
  9. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?
    J Neurol Sci. 2006 Jun 15;245(1-2):123-6 PMID: 16650874
  10. Revised diagnostic criteria for neuromyelitis optica.
    Neurology. 2006 May 23;66(10):1485-9 PMID: 16717206
  11. Magnetic resonance evidence of cortical onset of multiple sclerosis.
    Mult Scler. 2009 Aug;15(8):933-41 PMID: 19667021
  12. Chronic relapsing EAE. Time course of neurological symptoms and pathology.
    Acta Neuropathol. 1978 Aug 7;43(1-2):35-42 PMID: 676685
  13. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
    Nature. 2009 Nov 5;462(7269):94-8 PMID: 19829296
  14. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.
    Neurology. 2009 Apr 14;72(15):1330-6 PMID: 19365054
  15. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Mult Scler. 2009 Jan;15(1):36-41 PMID: 18755823
  16. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases.
    J Neurol Neurosurg Psychiatry. 1975 Jun;38(6):585-91 PMID: 239102
  17. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
    Neurology. 2003 Apr 8;60(7):1157-62 PMID: 12682324
  18. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
    Ann Neurol. 2001 Sep;50(3):389-400 PMID: 11558796
  19. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.
    Mult Scler. 2003 Aug;9(4):323-31 PMID: 12926836
  20. New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
    Ann Neurol. 1983 Mar;13(3):227-31 PMID: 6847134
  21. How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes.
    Blood. 2006 Jan 15;107(2):806-12 PMID: 16204309
  22. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.
    Brain. 2007 Apr;130(Pt 4):1089-104 PMID: 17438020
  23. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.
    Nat Immunol. 2009 May;10(5):514-23 PMID: 19305396
  24. The distribution of plaques in the cerebrum in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 1962 Nov;25:315-20 PMID: 14016083
  25. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.
    Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11064-9 PMID: 15263096
  26. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.
    J Comp Neurol. 2007 May 10;502(2):236-60 PMID: 17348011
  27. Grey matter pathology in multiple sclerosis.
    J Neuropathol Exp Neurol. 2005 Dec;64(12):1101-7 PMID: 16319720
  28. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis.
    Brain. 2011 Feb;134(Pt 2):534-41 PMID: 21216828
  29. Cortical lesions in children with multiple sclerosis.
    Neurology. 2011 Mar 8;76(10):910-3 PMID: 21383327
  30. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.
    Neurology. 2006 Sep 26;67(6):960-7 PMID: 17000961
  31. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    J Neurol Sci. 2009 Jul 15;282(1-2):106-11 PMID: 19100997
  32. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.
    Brain. 2004 May;127(Pt 5):1101-7 PMID: 14998914
  33. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
    Ann Neurol. 2000 Jun;47(6):707-17 PMID: 10852536
  34. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Brain. 2005 Nov;128(Pt 11):2705-12 PMID: 16230320
  35. Histogenesis of demyelinating lesions in the spinal cord of guinea pigs with chronic relapsing experimental allergic encephalomyelitis.
    J Neurol Sci. 1981 Apr;50(1):109-21 PMID: 7229654
  36. Monocyte/macrophage differentiation in early multiple sclerosis lesions.
    Ann Neurol. 1995 Nov;38(5):788-96 PMID: 7486871
  37. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
    Arch Neurol. 2007 Oct;64(10):1416-22 PMID: 17923625
  38. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis.
    Ann Neurol. 2009 Apr;65(4):457-69 PMID: 18496841
  39. Cortical pathology and cognitive impairment in multiple sclerosis.
    Expert Rev Neurother. 2011 Mar;11(3):425-32 PMID: 21375447
  40. Segmentation of cortical MS lesions on MRI using automated laminar profile shape analysis.
    Med Image Comput Comput Assist Interv. 2010;13(Pt 3):181-8 PMID: 20879398
  41. A case of multiple sclerosis presenting with inflammatory cortical demyelination.
    Neurology. 2011 May 17;76(20):1705-10 PMID: 21576686
  42. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.
    Brain. 2008 Jul;131(Pt 7):1759-75 PMID: 18535080
  43. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis.
    J Neurol. 2008 Apr;255(4):581-6 PMID: 18227989
  44. Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE.
    J Mol Med (Berl). 2009 Mar;87(3):273-86 PMID: 19050840
  45. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.
    Neurology. 2010 Nov 30;75(22):1988-94 PMID: 21115953
  46. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node.
    J Exp Med. 2002 Oct 21;196(8):1079-90 PMID: 12391019
  47. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis.
    Acta Neuropathol. 1986;70(2):149-60 PMID: 3488634
  48. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease.
    J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1693-7 PMID: 16291895
  49. 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions.
    J Magn Reson Imaging. 2010 Oct;32(4):971-7 PMID: 20882628
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2011-12-08
Pages
2188-97
Language
English
Region
United States
NLM ID
0255562
PMCID
PMC3282172
Subset
IM
Grants
NINDS NIH HHS · R01 NS049577 · United States
NINDS NIH HHS · P50NS38667 · United States
NINDS NIH HHS · P50 NS038667-13 · United States
NINDS NIH HHS · P50 NS038667 · United States
NINDS NIH HHS · 1R01NS049577 · United States
NINDS NIH HHS · R01 NS049577-07 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com